‘Unprecedented Story’: Revoked EU Marketing Authorization Fails To Thwart Translarna Sales

 
• By Francesca Bruce
  
PTC Therapeutics retains European sales of DMD treatment Translarna despite conditional marketing authorization withdrawal (Shutterstock)

More from Market Access

More from Europe